People with type 2 diabetes are often given medications including insulin to help manage their blood glucose levels. Most of these medications are in the form of tablets, but some are given by injection. Tablets or injections are intended to be used in conjunction with healthy eating and regular physical activity, not as a substitute.

The global Type 2 Diabetes Medication market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Type 2 Diabetes Medication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Type 2 Diabetes Medication.

Report Scope

The Type 2 Diabetes Medication market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Type 2 Diabetes Medication market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Type 2 Diabetes Medication companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Type 2 Diabetes Medication Market Report

Report Metric	Details
Report Name	Type 2 Diabetes Medication Market
CAGR	5%
Segment by Type	Biguanides Sulphonylureas Thiazolidinediones Alpha-glucosidase Inhibitors DPP-4 Inhibitors GLP-1 Receptor Agonists SGLT-2 Inhibitors Insulins
Segment by Application	Hospital Pharmacies Retail Pharmacies Online Pharmacies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AstraZeneca, Novartis, Novo Nordisk, Johnson & Johnson, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, Merck, Sanofi, Pfizer, Astellas Pharma, Daiichi Sankyo, Biocon, Glenmark, Bayer AG, Takeda, Sun pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Type 2 Diabetes Medication companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Type 2 Diabetes Medication Market report?

Ans: The main players in the Type 2 Diabetes Medication Market are AstraZeneca, Novartis, Novo Nordisk, Johnson & Johnson, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, Merck, Sanofi, Pfizer, Astellas Pharma, Daiichi Sankyo, Biocon, Glenmark, Bayer AG, Takeda, Sun pharma

What are the Application segmentation covered in the Type 2 Diabetes Medication Market report?

Ans: The Applications covered in the Type 2 Diabetes Medication Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Type 2 Diabetes Medication Market report?

Ans: The Types covered in the Type 2 Diabetes Medication Market report are Biguanides, Sulphonylureas, Thiazolidinediones, Alpha-glucosidase Inhibitors, DPP-4 Inhibitors, GLP-1 Receptor Agonists, SGLT-2 Inhibitors, Insulins

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Type 2 Diabetes Medication Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Biguanides

1.2.3 Sulphonylureas

1.2.4 Thiazolidinediones

1.2.5 Alpha-glucosidase Inhibitors

1.2.6 DPP-4 Inhibitors

1.2.7 GLP-1 Receptor Agonists

1.2.8 SGLT-2 Inhibitors

1.2.9 Insulins

1.3 Market by Application

1.3.1 Global Type 2 Diabetes Medication Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Type 2 Diabetes Medication Market Perspective (2019-2030)

2.2 Type 2 Diabetes Medication Growth Trends by Region

2.2.1 Global Type 2 Diabetes Medication Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Type 2 Diabetes Medication Historic Market Size by Region (2019-2024)

2.2.3 Type 2 Diabetes Medication Forecasted Market Size by Region (2025-2030)

2.3 Type 2 Diabetes Medication Market Dynamics

2.3.1 Type 2 Diabetes Medication Industry Trends

2.3.2 Type 2 Diabetes Medication Market Drivers

2.3.3 Type 2 Diabetes Medication Market Challenges

2.3.4 Type 2 Diabetes Medication Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Type 2 Diabetes Medication Players by Revenue

3.1.1 Global Top Type 2 Diabetes Medication Players by Revenue (2019-2024)

3.1.2 Global Type 2 Diabetes Medication Revenue Market Share by Players (2019-2024)

3.2 Global Type 2 Diabetes Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Type 2 Diabetes Medication Revenue

3.4 Global Type 2 Diabetes Medication Market Concentration Ratio

3.4.1 Global Type 2 Diabetes Medication Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Type 2 Diabetes Medication Revenue in 2023

3.5 Type 2 Diabetes Medication Key Players Head office and Area Served

3.6 Key Players Type 2 Diabetes Medication Product Solution and Service

3.7 Date of Enter into Type 2 Diabetes Medication Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Type 2 Diabetes Medication Breakdown Data by Type

4.1 Global Type 2 Diabetes Medication Historic Market Size by Type (2019-2024)

4.2 Global Type 2 Diabetes Medication Forecasted Market Size by Type (2025-2030)

5 Type 2 Diabetes Medication Breakdown Data by Application

5.1 Global Type 2 Diabetes Medication Historic Market Size by Application (2019-2024)

5.2 Global Type 2 Diabetes Medication Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Type 2 Diabetes Medication Market Size (2019-2030)

6.2 North America Type 2 Diabetes Medication Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Type 2 Diabetes Medication Market Size by Country (2019-2024)

6.4 North America Type 2 Diabetes Medication Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Type 2 Diabetes Medication Market Size (2019-2030)

7.2 Europe Type 2 Diabetes Medication Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Type 2 Diabetes Medication Market Size by Country (2019-2024)

7.4 Europe Type 2 Diabetes Medication Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Type 2 Diabetes Medication Market Size (2019-2030)

8.2 Asia-Pacific Type 2 Diabetes Medication Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Type 2 Diabetes Medication Market Size by Region (2019-2024)

8.4 Asia-Pacific Type 2 Diabetes Medication Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Type 2 Diabetes Medication Market Size (2019-2030)

9.2 Latin America Type 2 Diabetes Medication Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Type 2 Diabetes Medication Market Size by Country (2019-2024)

9.4 Latin America Type 2 Diabetes Medication Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Type 2 Diabetes Medication Market Size (2019-2030)

10.2 Middle East & Africa Type 2 Diabetes Medication Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Type 2 Diabetes Medication Market Size by Country (2019-2024)

10.4 Middle East & Africa Type 2 Diabetes Medication Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AstraZeneca

11.1.1 AstraZeneca Company Detail

11.1.2 AstraZeneca Business Overview

11.1.3 AstraZeneca Type 2 Diabetes Medication Introduction

11.1.4 AstraZeneca Revenue in Type 2 Diabetes Medication Business (2019-2024)

11.1.5 AstraZeneca Recent Development

11.2 Novartis

11.2.1 Novartis Company Detail

11.2.2 Novartis Business Overview

11.2.3 Novartis Type 2 Diabetes Medication Introduction

11.2.4 Novartis Revenue in Type 2 Diabetes Medication Business (2019-2024)

11.2.5 Novartis Recent Development

11.3 Novo Nordisk

11.3.1 Novo Nordisk Company Detail

11.3.2 Novo Nordisk Business Overview

11.3.3 Novo Nordisk Type 2 Diabetes Medication Introduction

11.3.4 Novo Nordisk Revenue in Type 2 Diabetes Medication Business (2019-2024)

11.3.5 Novo Nordisk Recent Development

11.4 Johnson & Johnson

11.4.1 Johnson & Johnson Company Detail

11.4.2 Johnson & Johnson Business Overview

11.4.3 Johnson & Johnson Type 2 Diabetes Medication Introduction

11.4.4 Johnson & Johnson Revenue in Type 2 Diabetes Medication Business (2019-2024)

11.4.5 Johnson & Johnson Recent Development

11.5 Boehringer Ingelheim

11.5.1 Boehringer Ingelheim Company Detail

11.5.2 Boehringer Ingelheim Business Overview

11.5.3 Boehringer Ingelheim Type 2 Diabetes Medication Introduction

11.5.4 Boehringer Ingelheim Revenue in Type 2 Diabetes Medication Business (2019-2024)

11.5.5 Boehringer Ingelheim Recent Development

11.6 Bristol-Myers Squibb

11.6.1 Bristol-Myers Squibb Company Detail

11.6.2 Bristol-Myers Squibb Business Overview

11.6.3 Bristol-Myers Squibb Type 2 Diabetes Medication Introduction

11.6.4 Bristol-Myers Squibb Revenue in Type 2 Diabetes Medication Business (2019-2024)

11.6.5 Bristol-Myers Squibb Recent Development

11.7 Eli Lilly

11.7.1 Eli Lilly Company Detail

11.7.2 Eli Lilly Business Overview

11.7.3 Eli Lilly Type 2 Diabetes Medication Introduction

11.7.4 Eli Lilly Revenue in Type 2 Diabetes Medication Business (2019-2024)

11.7.5 Eli Lilly Recent Development

11.8 Merck

11.8.1 Merck Company Detail

11.8.2 Merck Business Overview

11.8.3 Merck Type 2 Diabetes Medication Introduction

11.8.4 Merck Revenue in Type 2 Diabetes Medication Business (2019-2024)

11.8.5 Merck Recent Development

11.9 Sanofi

11.9.1 Sanofi Company Detail

11.9.2 Sanofi Business Overview

11.9.3 Sanofi Type 2 Diabetes Medication Introduction

11.9.4 Sanofi Revenue in Type 2 Diabetes Medication Business (2019-2024)

11.9.5 Sanofi Recent Development

11.10 Pfizer

11.10.1 Pfizer Company Detail

11.10.2 Pfizer Business Overview

11.10.3 Pfizer Type 2 Diabetes Medication Introduction

11.10.4 Pfizer Revenue in Type 2 Diabetes Medication Business (2019-2024)

11.10.5 Pfizer Recent Development

11.11 Astellas Pharma

11.11.1 Astellas Pharma Company Detail

11.11.2 Astellas Pharma Business Overview

11.11.3 Astellas Pharma Type 2 Diabetes Medication Introduction

11.11.4 Astellas Pharma Revenue in Type 2 Diabetes Medication Business (2019-2024)

11.11.5 Astellas Pharma Recent Development

11.12 Daiichi Sankyo

11.12.1 Daiichi Sankyo Company Detail

11.12.2 Daiichi Sankyo Business Overview

11.12.3 Daiichi Sankyo Type 2 Diabetes Medication Introduction

11.12.4 Daiichi Sankyo Revenue in Type 2 Diabetes Medication Business (2019-2024)

11.12.5 Daiichi Sankyo Recent Development

11.13 Biocon

11.13.1 Biocon Company Detail

11.13.2 Biocon Business Overview

11.13.3 Biocon Type 2 Diabetes Medication Introduction

11.13.4 Biocon Revenue in Type 2 Diabetes Medication Business (2019-2024)

11.13.5 Biocon Recent Development

11.14 Glenmark

11.14.1 Glenmark Company Detail

11.14.2 Glenmark Business Overview

11.14.3 Glenmark Type 2 Diabetes Medication Introduction

11.14.4 Glenmark Revenue in Type 2 Diabetes Medication Business (2019-2024)

11.14.5 Glenmark Recent Development

11.15 Bayer AG

11.15.1 Bayer AG Company Detail

11.15.2 Bayer AG Business Overview

11.15.3 Bayer AG Type 2 Diabetes Medication Introduction

11.15.4 Bayer AG Revenue in Type 2 Diabetes Medication Business (2019-2024)

11.15.5 Bayer AG Recent Development

11.16 Takeda

11.16.1 Takeda Company Detail

11.16.2 Takeda Business Overview

11.16.3 Takeda Type 2 Diabetes Medication Introduction

11.16.4 Takeda Revenue in Type 2 Diabetes Medication Business (2019-2024)

11.16.5 Takeda Recent Development

11.17 Sun pharma

11.17.1 Sun pharma Company Detail

11.17.2 Sun pharma Business Overview

11.17.3 Sun pharma Type 2 Diabetes Medication Introduction

11.17.4 Sun pharma Revenue in Type 2 Diabetes Medication Business (2019-2024)

11.17.5 Sun pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global Type 2 Diabetes Medication Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Biguanides

Table 3. Key Players of Sulphonylureas

Table 4. Key Players of Thiazolidinediones

Table 5. Key Players of Alpha-glucosidase Inhibitors

Table 6. Key Players of DPP-4 Inhibitors

Table 7. Key Players of GLP-1 Receptor Agonists

Table 8. Key Players of SGLT-2 Inhibitors

Table 9. Key Players of Insulins

Table 10. Global Type 2 Diabetes Medication Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 11. Global Type 2 Diabetes Medication Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 12. Global Type 2 Diabetes Medication Market Size by Region (2019-2024) & (US$ Million)

Table 13. Global Type 2 Diabetes Medication Market Share by Region (2019-2024)

Table 14. Global Type 2 Diabetes Medication Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 15. Global Type 2 Diabetes Medication Market Share by Region (2025-2030)

Table 16. Type 2 Diabetes Medication Market Trends

Table 17. Type 2 Diabetes Medication Market Drivers

Table 18. Type 2 Diabetes Medication Market Challenges

Table 19. Type 2 Diabetes Medication Market Restraints

Table 20. Global Type 2 Diabetes Medication Revenue by Players (2019-2024) & (US$ Million)

Table 21. Global Type 2 Diabetes Medication Market Share by Players (2019-2024)

Table 22. Global Top Type 2 Diabetes Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type 2 Diabetes Medication as of 2023)

Table 23. Ranking of Global Top Type 2 Diabetes Medication Companies by Revenue (US$ Million) in 2023

Table 24. Global 5 Largest Players Market Share by Type 2 Diabetes Medication Revenue (CR5 and HHI) & (2019-2024)

Table 25. Key Players Headquarters and Area Served

Table 26. Key Players Type 2 Diabetes Medication Product Solution and Service

Table 27. Date of Enter into Type 2 Diabetes Medication Market

Table 28. Mergers & Acquisitions, Expansion Plans

Table 29. Global Type 2 Diabetes Medication Market Size by Type (2019-2024) & (US$ Million)

Table 30. Global Type 2 Diabetes Medication Revenue Market Share by Type (2019-2024)

Table 31. Global Type 2 Diabetes Medication Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 32. Global Type 2 Diabetes Medication Revenue Market Share by Type (2025-2030)

Table 33. Global Type 2 Diabetes Medication Market Size by Application (2019-2024) & (US$ Million)

Table 34. Global Type 2 Diabetes Medication Revenue Market Share by Application (2019-2024)

Table 35. Global Type 2 Diabetes Medication Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 36. Global Type 2 Diabetes Medication Revenue Market Share by Application (2025-2030)

Table 37. North America Type 2 Diabetes Medication Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America Type 2 Diabetes Medication Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America Type 2 Diabetes Medication Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe Type 2 Diabetes Medication Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Europe Type 2 Diabetes Medication Market Size by Country (2019-2024) & (US$ Million)

Table 42. Europe Type 2 Diabetes Medication Market Size by Country (2025-2030) & (US$ Million)

Table 43. Asia-Pacific Type 2 Diabetes Medication Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 44. Asia-Pacific Type 2 Diabetes Medication Market Size by Region (2019-2024) & (US$ Million)

Table 45. Asia-Pacific Type 2 Diabetes Medication Market Size by Region (2025-2030) & (US$ Million)

Table 46. Latin America Type 2 Diabetes Medication Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Latin America Type 2 Diabetes Medication Market Size by Country (2019-2024) & (US$ Million)

Table 48. Latin America Type 2 Diabetes Medication Market Size by Country (2025-2030) & (US$ Million)

Table 49. Middle East & Africa Type 2 Diabetes Medication Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 50. Middle East & Africa Type 2 Diabetes Medication Market Size by Country (2019-2024) & (US$ Million)

Table 51. Middle East & Africa Type 2 Diabetes Medication Market Size by Country (2025-2030) & (US$ Million)

Table 52. AstraZeneca Company Detail

Table 53. AstraZeneca Business Overview

Table 54. AstraZeneca Type 2 Diabetes Medication Product

Table 55. AstraZeneca Revenue in Type 2 Diabetes Medication Business (2019-2024) & (US$ Million)

Table 56. AstraZeneca Recent Development

Table 57. Novartis Company Detail

Table 58. Novartis Business Overview

Table 59. Novartis Type 2 Diabetes Medication Product

Table 60. Novartis Revenue in Type 2 Diabetes Medication Business (2019-2024) & (US$ Million)

Table 61. Novartis Recent Development

Table 62. Novo Nordisk Company Detail

Table 63. Novo Nordisk Business Overview

Table 64. Novo Nordisk Type 2 Diabetes Medication Product

Table 65. Novo Nordisk Revenue in Type 2 Diabetes Medication Business (2019-2024) & (US$ Million)

Table 66. Novo Nordisk Recent Development

Table 67. Johnson & Johnson Company Detail

Table 68. Johnson & Johnson Business Overview

Table 69. Johnson & Johnson Type 2 Diabetes Medication Product

Table 70. Johnson & Johnson Revenue in Type 2 Diabetes Medication Business (2019-2024) & (US$ Million)

Table 71. Johnson & Johnson Recent Development

Table 72. Boehringer Ingelheim Company Detail

Table 73. Boehringer Ingelheim Business Overview

Table 74. Boehringer Ingelheim Type 2 Diabetes Medication Product

Table 75. Boehringer Ingelheim Revenue in Type 2 Diabetes Medication Business (2019-2024) & (US$ Million)

Table 76. Boehringer Ingelheim Recent Development

Table 77. Bristol-Myers Squibb Company Detail

Table 78. Bristol-Myers Squibb Business Overview

Table 79. Bristol-Myers Squibb Type 2 Diabetes Medication Product

Table 80. Bristol-Myers Squibb Revenue in Type 2 Diabetes Medication Business (2019-2024) & (US$ Million)

Table 81. Bristol-Myers Squibb Recent Development

Table 82. Eli Lilly Company Detail

Table 83. Eli Lilly Business Overview

Table 84. Eli Lilly Type 2 Diabetes Medication Product

Table 85. Eli Lilly Revenue in Type 2 Diabetes Medication Business (2019-2024) & (US$ Million)

Table 86. Eli Lilly Recent Development

Table 87. Merck Company Detail

Table 88. Merck Business Overview

Table 89. Merck Type 2 Diabetes Medication Product

Table 90. Merck Revenue in Type 2 Diabetes Medication Business (2019-2024) & (US$ Million)

Table 91. Merck Recent Development

Table 92. Sanofi Company Detail

Table 93. Sanofi Business Overview

Table 94. Sanofi Type 2 Diabetes Medication Product

Table 95. Sanofi Revenue in Type 2 Diabetes Medication Business (2019-2024) & (US$ Million)

Table 96. Sanofi Recent Development

Table 97. Pfizer Company Detail

Table 98. Pfizer Business Overview

Table 99. Pfizer Type 2 Diabetes Medication Product

Table 100. Pfizer Revenue in Type 2 Diabetes Medication Business (2019-2024) & (US$ Million)

Table 101. Pfizer Recent Development

Table 102. Astellas Pharma Company Detail

Table 103. Astellas Pharma Business Overview

Table 104. Astellas Pharma Type 2 Diabetes Medication Product

Table 105. Astellas Pharma Revenue in Type 2 Diabetes Medication Business (2019-2024) & (US$ Million)

Table 106. Astellas Pharma Recent Development

Table 107. Daiichi Sankyo Company Detail

Table 108. Daiichi Sankyo Business Overview

Table 109. Daiichi Sankyo Type 2 Diabetes Medication Product

Table 110. Daiichi Sankyo Revenue in Type 2 Diabetes Medication Business (2019-2024) & (US$ Million)

Table 111. Daiichi Sankyo Recent Development

Table 112. Biocon Company Detail

Table 113. Biocon Business Overview

Table 114. Biocon Type 2 Diabetes Medication Product

Table 115. Biocon Revenue in Type 2 Diabetes Medication Business (2019-2024) & (US$ Million)

Table 116. Biocon Recent Development

Table 117. Glenmark Company Detail

Table 118. Glenmark Business Overview

Table 119. Glenmark Type 2 Diabetes Medication Product

Table 120. Glenmark Revenue in Type 2 Diabetes Medication Business (2019-2024) & (US$ Million)

Table 121. Glenmark Recent Development

Table 122. Bayer AG Company Detail

Table 123. Bayer AG Business Overview

Table 124. Bayer AG Type 2 Diabetes Medication Product

Table 125. Bayer AG Revenue in Type 2 Diabetes Medication Business (2019-2024) & (US$ Million)

Table 126. Bayer AG Recent Development

Table 127. Takeda Company Detail

Table 128. Takeda Business Overview

Table 129. Takeda Type 2 Diabetes Medication Product

Table 130. Takeda Revenue in Type 2 Diabetes Medication Business (2019-2024) & (US$ Million)

Table 131. Takeda Recent Development

Table 132. Sun pharma Company Detail

Table 133. Sun pharma Business Overview

Table 134. Sun pharma Type 2 Diabetes Medication Product

Table 135. Sun pharma Revenue in Type 2 Diabetes Medication Business (2019-2024) & (US$ Million)

Table 136. Sun pharma Recent Development

Table 137. Research Programs/Design for This Report

Table 138. Key Data Information from Secondary Sources

Table 139. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Type 2 Diabetes Medication Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Type 2 Diabetes Medication Market Share by Type: 2023 VS 2030

Figure 3. Biguanides Features

Figure 4. Sulphonylureas Features

Figure 5. Thiazolidinediones Features

Figure 6. Alpha-glucosidase Inhibitors Features

Figure 7. DPP-4 Inhibitors Features

Figure 8. GLP-1 Receptor Agonists Features

Figure 9. SGLT-2 Inhibitors Features

Figure 10. Insulins Features

Figure 11. Global Type 2 Diabetes Medication Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 12. Global Type 2 Diabetes Medication Market Share by Application: 2023 VS 2030

Figure 13. Hospital Pharmacies Case Studies

Figure 14. Retail Pharmacies Case Studies

Figure 15. Online Pharmacies Case Studies

Figure 16. Type 2 Diabetes Medication Report Years Considered

Figure 17. Global Type 2 Diabetes Medication Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 18. Global Type 2 Diabetes Medication Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 19. Global Type 2 Diabetes Medication Market Share by Region: 2023 VS 2030

Figure 20. Global Type 2 Diabetes Medication Market Share by Players in 2023

Figure 21. Global Top Type 2 Diabetes Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type 2 Diabetes Medication as of 2023)

Figure 22. The Top 10 and 5 Players Market Share by Type 2 Diabetes Medication Revenue in 2023

Figure 23. North America Type 2 Diabetes Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. North America Type 2 Diabetes Medication Market Share by Country (2019-2030)

Figure 25. United States Type 2 Diabetes Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Canada Type 2 Diabetes Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Europe Type 2 Diabetes Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Europe Type 2 Diabetes Medication Market Share by Country (2019-2030)

Figure 29. Germany Type 2 Diabetes Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. France Type 2 Diabetes Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. U.K. Type 2 Diabetes Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Italy Type 2 Diabetes Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Russia Type 2 Diabetes Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Nordic Countries Type 2 Diabetes Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Asia-Pacific Type 2 Diabetes Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Asia-Pacific Type 2 Diabetes Medication Market Share by Region (2019-2030)

Figure 37. China Type 2 Diabetes Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Japan Type 2 Diabetes Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. South Korea Type 2 Diabetes Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Southeast Asia Type 2 Diabetes Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. India Type 2 Diabetes Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Australia Type 2 Diabetes Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Latin America Type 2 Diabetes Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Latin America Type 2 Diabetes Medication Market Share by Country (2019-2030)

Figure 45. Mexico Type 2 Diabetes Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Brazil Type 2 Diabetes Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East & Africa Type 2 Diabetes Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East & Africa Type 2 Diabetes Medication Market Share by Country (2019-2030)

Figure 49. Turkey Type 2 Diabetes Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Saudi Arabia Type 2 Diabetes Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. AstraZeneca Revenue Growth Rate in Type 2 Diabetes Medication Business (2019-2024)

Figure 52. Novartis Revenue Growth Rate in Type 2 Diabetes Medication Business (2019-2024)

Figure 53. Novo Nordisk Revenue Growth Rate in Type 2 Diabetes Medication Business (2019-2024)

Figure 54. Johnson & Johnson Revenue Growth Rate in Type 2 Diabetes Medication Business (2019-2024)

Figure 55. Boehringer Ingelheim Revenue Growth Rate in Type 2 Diabetes Medication Business (2019-2024)

Figure 56. Bristol-Myers Squibb Revenue Growth Rate in Type 2 Diabetes Medication Business (2019-2024)

Figure 57. Eli Lilly Revenue Growth Rate in Type 2 Diabetes Medication Business (2019-2024)

Figure 58. Merck Revenue Growth Rate in Type 2 Diabetes Medication Business (2019-2024)

Figure 59. Sanofi Revenue Growth Rate in Type 2 Diabetes Medication Business (2019-2024)

Figure 60. Pfizer Revenue Growth Rate in Type 2 Diabetes Medication Business (2019-2024)

Figure 61. Astellas Pharma Revenue Growth Rate in Type 2 Diabetes Medication Business (2019-2024)

Figure 62. Daiichi Sankyo Revenue Growth Rate in Type 2 Diabetes Medication Business (2019-2024)

Figure 63. Biocon Revenue Growth Rate in Type 2 Diabetes Medication Business (2019-2024)

Figure 64. Glenmark Revenue Growth Rate in Type 2 Diabetes Medication Business (2019-2024)

Figure 65. Bayer AG Revenue Growth Rate in Type 2 Diabetes Medication Business (2019-2024)

Figure 66. Takeda Revenue Growth Rate in Type 2 Diabetes Medication Business (2019-2024)

Figure 67. Sun pharma Revenue Growth Rate in Type 2 Diabetes Medication Business (2019-2024)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions